Your browser doesn't support javascript.
loading
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Carrie, Christian; Magné, Nicolas; Burban-Provost, Patricia; Sargos, Paul; Latorzeff, Igor; Lagrange, Jean-Léon; Supiot, Stéphane; Belkacemi, Yazid; Peiffert, Didier; Allouache, Nedla; Dubray, Bernard M; Servagi-Vernat, Stéphanie; Suchaud, Jean-Philippe; Crehange, Gilles; Guerif, Stéphane; Brihoum, Meryem; Barbier, Nicolas; Graff-Cailleaud, Pierre; Ruffion, Alain; Dussart, Sophie; Ferlay, Céline; Chabaud, Sylvie.
Afiliación
  • Carrie C; Radiotherapy Department, Léon Bérard Center, Lyon, France; CNRS UMR 5220, INSERM U1044, INSA, University of Lyon, Lyon, France. Electronic address: christian.carrie@lyon.unicancer.fr.
  • Magné N; Cellular and Molecular Radiobiology, Lucien Neuwirth Cancer Institute, and Institute of Nuclear Physics of Lyon, Lyon-Sud Faculty of Medicine, Lyon, France.
  • Burban-Provost P; private hospital of Cotes D'armor, Plerin, France.
  • Sargos P; Radiotherapy Department, Bergonié Institute, Bordeaux, France.
  • Latorzeff I; Clinique Pasteur Groupe Oncorad Garonne, Toulouse, France.
  • Lagrange JL; Henri Mondor Breast Center, Créteil, France.
  • Supiot S; René Gauducheau cancer Institute, Nantes, France.
  • Belkacemi Y; Department of Radiation Oncology and Henri Mondor Breast Center, University of Paris-Est, Créteil, France.
  • Peiffert D; Lorraine Cancer Institute, Alexis Vautrin Cancer Center, Université de Lorraine, Faculté de Médecine, Vandoeuvre-les-Nancy, France.
  • Allouache N; François Baclesse Cancer Center, Caen, France.
  • Dubray BM; Henri Becquerel Cancer Center, Rouen, France.
  • Servagi-Vernat S; Jean Godinot Institute, Reims, France.
  • Suchaud JP; Radiotherapy Department, Roanne hospital center, Roanne, France.
  • Crehange G; Georges-François Leclerc Cancer Center, Dijon, France.
  • Guerif S; University hospital of Poitiers, Poitiers, France.
  • Brihoum M; UNICANCER, Paris, France.
  • Barbier N; Catalan Cancer Center, Perpignan, France.
  • Graff-Cailleaud P; University Institute of Cancer Toulouse-Oncopôle, Toulouse, France.
  • Ruffion A; Urology Department, Hospices Civils de Lyon, Pierre-Bénite, France.
  • Dussart S; Biostatistics Unit, Clinical Research and Innovation Department, Léon Bérard Cancer Centre, Lyon, France.
  • Ferlay C; Biostatistics Unit, Clinical Research and Innovation Department, Léon Bérard Cancer Centre, Lyon, France.
  • Chabaud S; Biostatistics Unit, Clinical Research and Innovation Department, Léon Bérard Cancer Centre, Lyon, France.
Lancet Oncol ; 20(12): 1740-1749, 2019 12.
Article en En | MEDLINE | ID: mdl-31629656
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prostatectomía / Neoplasias de la Próstata / Adenocarcinoma / Terapia Recuperativa / Radioterapia Conformacional / Quimioradioterapia / Antagonistas de Andrógenos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prostatectomía / Neoplasias de la Próstata / Adenocarcinoma / Terapia Recuperativa / Radioterapia Conformacional / Quimioradioterapia / Antagonistas de Andrógenos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido